Fig 2: (a) PCR determination of VRK1 mRNA expression levels in cancer tissues of 25 clinical pairs of LUSC patients and their paraneoplastic normal tissues; (b) WB detection of VRK1 protein expression in three pairs of cancer and paraneoplastic tissues; (c) quantitative plots.

Fig 3: (a) VRK1 mRNA levels in the BEAS-2B cell line and five LUSC cell lines; (b) WB validation of NCI-H520 knockdown VRK1 efficiency and (c) quantification plots; (d) WB validation of SK-MES-1 knockdown VRK1 efficiency; and (e) quantification plots.